Rare diseases
Investigational molecules
Locations
Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
GreeceLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GreeceOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GreeceA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
GreeceStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
GreeceA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GreeceA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GreeceA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
GreeceA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
GreeceA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
GreeceA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
GreeceA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
GreeceTell us about your condition – we search every trial in Europe and connect you with the right site.
